Medical technology company Motus GI is offering $20 million in common stock priced at $3 a share to the public to fund commercialization of its Pure-Vu system for colonoscopies.
Key details:
1. The offering, which includes 6,666,667 shares, is expected to close July 1.
2. In addition to commercialization, Motus GI plans to use the proceeds from the stock sales to continue research and development of the Pure-Vu system, as well as to license additional technologies.
3. MotusGI granted the underwriters a 30-day option to purchase 1 million additional shares.